Medtronic’s MiniMed 600 series insulin pumps potentially at risk of compromise, says FDA
Categories: Exploits and vulnerabilities Categories: News Medtronic, an insulin pump company, notified its users of a potential risk of attack due to a flaw in its pump’s communication protocol. |
The post Medtronic’s MiniMed 600 series insulin pumps potentially at risk of compromise, says FDA appeared first on Malwarebytes Labs.